|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Feb 1, 2025
|
FY2024
12 months to Feb 3, 2024
|
FY2023
12 months to Jan 28, 2023
|
FY2022
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Cash flows provided by operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Depreciation and amortization | |||||
| Share-based and performance-based stock compensation | |||||
| Deferred taxes | |||||
| Provision/(adjustments) for doubtful accounts | |||||
| Loss/(Gain) on disposal of property and equipment | |||||
| Net change in film costs and advances | |||||
| Change in assets and liabilities: | |||||
| Inventories, net | |||||
| Receivables, net | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Operating leases | |||||
| Gift cards and customer deposits | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows used in investing activities: | |||||
| Capital expenditures | |||||
| Net cash used in investing activities | |||||
| Cash flows used in financing activities: | |||||
| Line of credit amendment fee | |||||
| Purchases of common stock for employee equity awards, net of tax | |||||
| Purchases of Company's common stock | |||||
| Cash dividends paid on vested participating securities | |||||
| Net cash used in financing activities | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Net cash paid during the period for income taxes | |||||
| Effect of exchange rates on cash | |||||
| Reconciliation of cash, cash equivalents and restricted cash (1) | |||||
| Cash and cash equivalents | |||||
| Restricted cash from long-term deposits | |||||
Loading...